Company: GNMSF
Filing Date: 2025-12-30
Form Type: SCHEDULE 13D/A
Source: 0001193125-25-337294
Chunk: 0

Company: GENMAB A/S
Filing Date: 2025-12-30
Form: SCHEDULE 13D/A
Chunk 0
---
the "SEC") on December 30, 2025, amends and supplements the statement on Schedule 13D filed with the SEC on December 19, 2025, by (i) Genmab A/S, a public limited liability company (Aktieselskab) organized under the laws of Denmark ("Parent"), and (ii) Genmab Holding II B.V., a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) organized under the laws of The Netherlands ("Purchaser") and a wholly owned subsidiary of Parent (as it may be amended or supplemented from time to time and together with the exhibits thereto, the "Schedule 13D").  The Schedule 13D relates to the tender offer by Purchaser to purchase all of the issued and outstanding common shares, Euro 0.09 nominal value per share (each, a "Common Share," and collectively, the "Common Shares"), in the capital of Merus N.V., a public limited liability company (naamloze vennootschap) organized under the laws of The Netherlands (the "Issuer"), in exchange for an amount in cash equal to $97.00 per Common Share (such amount, the "Offer Consideration"), less any applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated October 21, 2025 (as it may be amended or supplemented from time to time, the "Offer to Purchase"), and in the letter of transmittal that accompanies the Offer to Purchase (the "Letter of Transmittal," and together with the Offer to Purchase and other related materials, as each may be amended or supplemented from time to time, the "Offer"), copies of which are attached as Exhibits C and D, respectively, to the Schedule 13D.  The Schedule 13D also relates to the Transaction Agreement, dated as of September 29, 2025, by and among Parent, Purchaser and the Issuer (the "Transaction Agreement"), pursuant to which the Offer was made, a copy of which is attached as Exhibit E to the Schedule 13D. 
 Except as otherwise set forth in this Amendment No. 1, the information set forth in the Schedule 13D, including all exhibits thereto, remains unchanged and is incorporated herein by reference with respect to all of the applicable items in this Amendment No. 1.  Capitalized terms